Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, (July 2012, ...

Researchers in the U.K. are launching a phase II trial to see if high doses of aspirin can help prevent permanent hearing loss, a common side effect among cancer patients given the chemotherapy drug ...

Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product Aspire anticipates releasing initial clinical data from trial at the end of the second ...

Please provide your email address to receive an email when new articles are posted on . Aspirin use increased risk in patients with chronic coronary syndrome on oral anticoagulation. The AQUATIC trial ...